With new drugs appearing on the toxicology landscape all too often Randox Toxicology is constantly working to develop new tests such as our NPS I and NPS II panels, helping to detect the latest new psychoactive substances that are continuing to appear on the market.
But what if there is a specific drug that is prevalent in your area that isn't one of our already established panels?
With this mind we have given our customers the opportunity to create their own custom arrays to suit their market. Using our award winning Biochip Array Technology you will have the freedom to design your own custom array that is tailored to suit your needs and remove the cost of unnecessary testing.
By testing up to 21 different drugs across a range of matrices, you will be able to reduce your employee workload and focus on the main drugs in your market. Available on our Evidence range of analysers you will be able to mix and match drug tests allowing a full test profile from a small sample volume.
If you would like to find out more about our custom arrays or the new NPS I and II panels testing for designer fentanyls, including carfentanil and opioids, please visit our Director of Sales for North America, Pankaj Sinha at booth 3 at NEAFS from the 7th - 10th November.
For further information please email us at email@example.com